148
Participants
Start Date
February 3, 2020
Primary Completion Date
March 31, 2030
Study Completion Date
March 31, 2030
Dexamethasone, cyclophosphamide, rituximab
DRC Arm (chemotherapy) consists of dexamethasone, cyclophosphamide and rituximab treatment
Rituximab, ibrutinib
RI Arm (chemotherapy free) consists of rituximab and ibrutinib treatment
RECRUITING
Royal United Hospital, Bath, Bath
RECRUITING
The Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust, Bournemouth
RECRUITING
East Kent Hospitals University NHS Foundation Trust, Canterbury
RECRUITING
University Hospital of Wales, Cardiff
RECRUITING
Colchester Hospital, Colchester
RECRUITING
Mid Yorkshire NHS Trust, Dewsbury
RECRUITING
Royal Devon University Hospital, Exeter
RECRUITING
Medway Maritime Hospital, Gillingham
RECRUITING
Castle Hill Hospital, Hull
RECRUITING
NHS Lanarkshire, Lanark
RECRUITING
St James's University Hospital, Leeds
RECRUITING
Leicester Royal Infirmary, Leicester
RECRUITING
Barking, Havering and Redbridge University Hospitals NHS Trust, London
RECRUITING
Barts Health NHS Trust, London
RECRUITING
King's College Hospital, London
RECRUITING
Northwick Park Hospital, London
RECRUITING
University College London Hospitals NHS Foundation Trust, London
RECRUITING
Christie NHS Foundation Trust, Manchester
RECRUITING
Norfolk and Norwich Hospital, Norwich
RECRUITING
Oxford University Hospital, Oxford
RECRUITING
University Hospitals Plymouth NHS Trust, Plymouth
RECRUITING
Salisbury NHS Foundation Trust, Salisbury
RECRUITING
Torbay & Newton Abbot Hospital, Torquay
RECRUITING
Royal Cornwall Hospital, Truro
RECRUITING
Hampshire Hospitals NHS Foundation Trust, Winchester
Janssen-Cilag Ltd.
INDUSTRY
University College, London
OTHER